SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-001537
Filing Date
2019-03-06
Accepted
2019-03-06 08:30:07
Documents
70
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K glyc-20181231x10k.htm 10-K 2394216
2 EX-23.1 glyc-20181231ex231a42d04.htm EX-23.1 10946
3 EX-31.1 glyc-20181231ex311f10844.htm EX-31.1 13048
4 EX-31.2 glyc-20181231ex3124d48a9.htm EX-31.2 13221
5 EX-32.1 glyc-20181231ex3215c5124.htm EX-32.1 11156
6 GRAPHIC glyc20181231x10k001.jpg GRAPHIC 190207
7 GRAPHIC glyc20181231x10k002.jpg GRAPHIC 76194
8 GRAPHIC glyc20181231x10k003.jpg GRAPHIC 79265
  Complete submission text file 0001558370-19-001537.txt   7366733

Data Files

Seq Description Document Type Size
9 EX-101.INS glyc-20181231.xml EX-101.INS 1314024
10 EX-101.SCH glyc-20181231.xsd EX-101.SCH 41718
11 EX-101.CAL glyc-20181231_cal.xml EX-101.CAL 40027
12 EX-101.DEF glyc-20181231_def.xml EX-101.DEF 155444
13 EX-101.LAB glyc-20181231_lab.xml EX-101.LAB 364414
14 EX-101.PRE glyc-20181231_pre.xml EX-101.PRE 299500
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36177 | Film No.: 19661316
SIC: 2834 Pharmaceutical Preparations